enhance the trustworthiness as well as increase confidence to business partners, investors, and distributors for future business expansion. 4.3 As the Company will be the sole operator for undertaking the
งวด 27.13 64.31 กระแสเงนิสดจากการด าเนินงานต่อส่วนของผู้ถือหุ้น เพิ่มขึน้ (ลดลง) (%) CFROE : Cash Flow Return on Equity 52.88% 42.68% กลุม่บริษัทมีเงินสดสทุธิได้มาจากกิจกรรมด าเนินงานในไตรมาสที่ 1/2561จ
. Despite, the Company issued newly ordinary shares and warrants totally worth 3,894 million baht to its existing shareholders as well as to the specific investor (Private Placement) in Q1 2018, and the
branded product by 3rd party manufacture remains stable as last year. For sales by channel, traditional trade reduced by THB 73 million or 7% while modern trade and cash van increased by THB 63 million or
distribution while branded product by 3rd party manufacture remains stable as last year. For sales by channel, traditional trade reduced by THB 73 million or 7% while modern trade and cash van increased by THB
clinical business which dialysis services for kidney patients who receive replacement therapy with dialysis by dialysis machinery (Dialysis Center) and distribution of medical equipment as well as medical
business which dialysis services for kidney patients who receive replacement therapy with dialysis by dialysis machinery (Dialysis Center) and distribution of medical equipment as well as medical service
VAT ID 0107538000151 Thailand W www.wiik-hoeglund.com Statements of financial position Million Baht 2017 (Audited) 2018 (Management statement) Assets Current assets Cash and cash equivalents 0.04 1.05